NOT KNOWN FACTUAL STATEMENTS ABOUT MBL77

Not all individuals with CLL call for therapy. In spite of all latest improvements, the iwCLL continue to recommends watchful observation for patients with asymptomatic illness.86 This advice is predicated on a minimum of two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (F